Parkridge Medical Center
advanced its commitment to high-tech heart care by implanting a patient with the city’s first Boston Scientific INCEPTA™ Cardiac Resynchronization Therapy Defibrillator (CRT-D) device for advanced heart failure management.
Incepta device works to regulate a person’s heartbeat and provides top
of the line wireless technology with state of the art arrhythmia
detection. It pairs with the Latitude heart failure management system,
which includes a special scale and blood pressure cuff that
automatically send patient data to the physician’s office when
measurements are taken. This may increase the benefits for patients and
physicians as it can minimize the number of in-person office visits that
a patient must make after undergoing a cardiac procedure.
Incepta CRT-D device is an advanced therapeutic tool whose
functionality can be adjusted to match specific patient needs,” said
interventional cardiologist Timothy Talbert, who performed the first
Incepta implantation procedure at Parkridge. “It is designed to be
easier for physicians to implant. It also has many benefits for patients
- this is a premium high-energy CRT-D device that is the world’s smallest and thinnest. It offers advanced battery technology with excellent longevity.”
have been proven in clinical studies to save and extend lives by
preventing sudden cardiac death (SCD) and treating heart failure. Each
year, SCD claims the lives of up to 460,000 people in the U.S. alone,
and more people die from SCD than from lung cancer, breast cancer and
technology is expected to help hospitals lower readmission rates for
heart failure patients by helping physicians to catch troublesome
changes in a patient’s weight or blood pressure before they become
serious enough to require rehospitalization,” notes Parkridge Heart
Center director Barry Bell.
22 million people worldwide currently suffer from heart failure, a
debilitating condition in which the heart weakens and gradually loses
the ability to pump blood effectively. Approximately one million new
cases of heart failure are diagnosed annually worldwide, making it the
most rapidly growing cardiovascular disorder.